IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 6784 
Small font sizeDefault font sizeIncrease font size
Read this article

 


    Article Cited by others

RESEARCH ARTICLE

A comparative study of efficacy and safety of febuxostat and allopurinol in pyrazinamide-induced hyperuricemic tubercular patients

Pichholiya Meenu, Yadav Arvind Kumar, Luhadia S K, Tahashildar Jameela, Aseri M L

Year : 2016| Volume: 48| Issue : 5 | Page no: 522-525

   This article has been cited by
 
1 Novel Antibacterial Activity of Febuxostat, an FDA-Approved Antigout Drug against Mycobacterium tuberculosis Infection
Lee-Han Kim, Soon Myung Kang, Jake Whang, Kee Woong Kwon, Sung Jae Shin
Antimicrobial Agents and Chemotherapy. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 ????????????? ? ??????? ????????????, ?????????? ? ???????? ????????, "??????? ???????????? ??????-?????????????????? ????????? ???????????"
?.?. ?????????, ?.?. ???????????, ?.?. ???????
??????? ?????. 2022; (1): 69
[Pubmed]  [Google Scholar] [DOI]
3 Allopurinol to reduce cardiovascular morbidity and mortality: A systematic review and meta-analysis
Karel H. van der Pol, Kimberley E. Wever, Mariette Verbakel, Frank L. J. Visseren, Jan H. Cornel, Gerard A. Rongen, Carmine Pizzi
PLOS ONE. 2021; 16(12): e0260844
[Pubmed]  [Google Scholar] [DOI]
4 Individualized homeopathic medicines and Urtica urens mother tincture in treatment of hyperuricemia: an open, randomized, pragmatic, pilot trial
Chintamani Nayak, Nivedita Pattanaik, Abhijit Chattopadhyay, Pankhuri Misra, Koushik Bhar, James Michael, Munmun Koley, Subhranil Saha
Journal of Complementary and Integrative Medicine. 2021; 18(3): 599
[Pubmed]  [Google Scholar] [DOI]

 

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow